Bilcare Share Price
95.85+4.56 (+5.00%)
+50.47% past 1 Year
Bilcare Ltd is engaged in manufacturing pharmaceutical packaging. The company develops designstaking into consideration various aspects such as end-user, optimum material, composite dosages, on-pack communication, cost-effective, regulatory requirements, etc.They also
Corporate filings & documents
Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Guttikonda Rajasekhar & Others
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Guttikonda Rajasekhar & Others
1 week agoBilcare Limited has informed the Exchange about the Newspaper Publication of Quarterly Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June 2026.
2 weeks agoBilcare Limited has informed the Exchange about the Newspaper Publication of Quarterly Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June 2026.
2 weeks agoBilcare Limited has informed the Exchange about the Voluntary winding up of wholly owned subsidiary.
3 weeks agoBilcare Limited has informed the Exchange about the appointment of Company Secretary Compliance Officer and Key Managerial Personnel
3 weeks agoBilcare Limited has informed the Exchange aabout the Resignation of Company Secretary Compliance Officer and Key Managerial Personnel
3 weeks agoBilcare Limited has informed the Exchange about the appointment of Mr. Mohan Bhandari as an Executive Director of the Company and reappointment of Ms. Kavita Bhansali as Executive Director of the Company.
3 weeks agoBilcare Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued by Statutory Auditors of the Company.
3 weeks agoBilcare Limitedhas informed the Exchange about the outcome of Board Meeting.
3 weeks agoBilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended on 30 June 2026
3 weeks agoBilcare Limited has submitted the Scrutinizers Report and Voting Results regarding Postal Ballot conducted.
1 month agoBilcare Limited has submitted the Scrutinizers Report and Voting Results regarding Postal Ballot conducted.
1 month agoBilcare Limited has submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
1 month agoBilcare Limited has submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
1 month agoBilcare Limited has submitted intimation towards closure of trading window.
2 months agoBilcare Limited has submitted intimation towards closure of trading window.
2 months agoBilcare Limited has informed the Exchange about Newspaper Publication regarding Postal Ballot Notice and Remote e-voting.
2 months agoBilcare Limited has informed the Exchange about Newspaper Publication regarding Postal Ballot Notice and Remote e-voting.
2 months agoBilcare Limited has informed the Exchange about Notice of Postal Ballot.
2 months agoBilcare Limited has informed the Exchange about Notice of Postal Ballot.
2 months agoBilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions 2015 - Order of Honble NCLT Mumbai Bench.
2 months agoBilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions 2015 - Order of Honble NCLT Mumbai Bench.
2 months agoBilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year Ended 31st March 2026.
3 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year Ended 31st March 2026.
3 months agoBilcare Limited has submitted the Annual Secretarial Compliance Report for the year ended on 31 March 2026.
3 months agoBilcare Limited has submitted the Annual Secretarial Compliance Report for the year ended on 31 March 2026.
3 months agoBilcare Limited has informed the Exchange about the following: a) Redemption of Preference Shares and b) Conversion of Warrants and Allotment of Equity Shares
3 months agoBilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results (Standalone and Consolidated) for the period ended on 31 March 2026
3 months agoBilcare Limited has informed the Exchange about the outcome of Board Meeting held on 29 May 2026
3 months agoBilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended on 31 March 2026.
3 months agoBilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended on 31 March 2026.
3 months agoBilcare Limited has informed the Exchange that the Non - applicability of Large Corporate Category.
4 months agoBilcare Limited has informed the Exchange about the Cessation due to Completion of Second Term as an Independent Director Mrs. Madhuri Vaidya effective from end of business hours on 26 April 2026.
4 months agoBilcare Limited has informed the Exchange about the1. Cessation due to Completion of Second term as an Independent Director Mrs. Madhuri Vaidya2. Appointment of Advocate Ashwini Ashok Hasabnis as an Additional Director of the Company3. Composition of Committee of the Board
4 months agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st March 2026.
4 months agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st March 2026.
4 months agoBilcare Limited has informed the Exchange about the update on Voluntary Liquidation of Wholly Owned Subsidiary Company.
5 months agoBilcare Limited has informed the Exchange about the update on Voluntary Liquidation of Wholly Owned Subsidiary Company.
5 months agoBilcare Limited has informed the Exchange about the Outcome of Board meeting held on March 30 2026.
5 months agoBilcare Limited has informed the Exchange about the following;a) Redemption of Preference Sharesb) Conversion of Warrants and Allotment of Equity Sharesc) Update on Voluntary liquidation of Wholly Owned Subsidiary
5 months agoIntimation of Closure of Trading Window for Audited Financial Results for the Quarter and Year ended March 31 2026
5 months agoNewspaper publication of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended 31st December 2025.
6 months agoBilcare Limited has informed the Exchange about that Exercise of Right of Conversion of Convertible Warrants
6 months agoBilcare Limited has informed the Exchange about that Exercise of Right of Conversion of Convertible Warrants
6 months agoBilcare Limited has informed the Exchange about the Redemption of Preference Shares held by the Company in Caprihans India Limited.
6 months agoBilcare Limited has informed the Exchange about the approval of Unaudited Financial Results (Standalone and Consolidated) for the period ended 31.12.2025 along with Limited Review Report.
6 months agoBilcare Limited has informed the exchange about the outcome of Board Meeting and approval of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.
6 months agoBilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Un-Audited Financial Results For The Quarter and Nine months ended December 31 2025.
6 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Gat No. 1028 Village Shiroli Rajgurunagar Khed Pune Maharashtra PIN: 410505 Tel No: 02135- 647501 / 647300 Fax No: 02135- 224068 Email: [email protected] Internet: www.bilcaregroup.com
Registrars
Block No 202, 2nd Floor, Akshay Complex, Near Ganesh Temple, Off Dhole Patil Road, Pune, Maharashtra Block No 202, 2nd Floor Akshay Complex, Near Ganesh Temple Off Dhole Patil Road PIN: Tel No: 020-26051629/0084 Fax No: 020-26053503 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Shreyans Bhandari, Chairman & Managing Director
Shreyans Bhandari, Chairman & Managing Director
Kavita Bhansali, Whole Time Director
Rajesh Devene, Non Executive Independent Director
Alka Sagar, Non Executive Independent Director
Sagar R Baheti, Company Secretary & Compliance Officer
Details
BSE 526853
NSE BI
ISIN INE986A01012